In today’s recent session, 0.65 million shares of the T2 Biosystems Inc (NASDAQ:TTOO) have been traded, and its beta is 0.01. Most recently the company’s share price was $5.00, and it changed around $0.84 or 20.19% from the last close, which brings the market valuation of the company to $43.95M. TTOO at last check was trading at a discount to its 52-week high of $70.00, offering almost -1300.0% off that amount. The share price’s 52-week low was $2.60, which indicates that the recent value has risen by an impressive 48.0% since then. We note from T2 Biosystems Inc’s average daily trading volume that its 3-month average coming to 288.12K.
T2 Biosystems Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended TTOO as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. T2 Biosystems Inc is expected to report earnings per share of -$0.97 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
T2 Biosystems Inc (NASDAQ:TTOO) trade information
Instantly TTOO has been showing a green trend so far today with a performance of 20.19% on intraday trading today. The performance over the last five days has remained in the green territory. The company’s shares are currently down -20.32% year-to-date, but still up 63.93% over the last five days. On the other hand, T2 Biosystems Inc (NASDAQ:TTOO) is 65.02% up in the 30-day period.
T2 Biosystems Inc (TTOO) estimates and forecasts
Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 99.30% in revenue this quarter, and will report an increase of 90.60% in the next quarter. The year-over-year growth rate is expected to be 46.00%, up from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of $2.1 million in revenue for the current quarter. 1 analysts expect T2 Biosystems Inc to make $2.7 million in revenue for the quarter ending Sep 2024. The company’s sales for the same quarters a year ago were $1.96 million and $1.47 million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 6.90%. Forecasts for the next quarter put sales growth at 83.40%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 68.62%.
